OBJECTIVE
To investigate the change in the expression of tight junction protein ZO-1 in intestinal epithelial cells (Caco-2 cells) and the protective effect of eicosapentaenoic acid (EPA) after adherent-invasive Escherichia coli (E.coli) LF82 infection.
METHODS
The Caco-2 cell line was used to establish an in vitro model of tight junction of intestinal epithelial cells. Caco-2 cells were divided into EPA treatment groups (0, 25, 50, 100, and 200 μmol/L EPA) and EPA (0, 25, 50, 100, and 200 μmol/L EPA)+E.coli LF82 treatment (0, 6, and 12 hours) groups. A microscope was used to observe the morphological characteristics of the cells. MTT assay was used to determine the cell growth curve. The activity of alkaline phosphatase (ALP) at both sides of the cell membrane was compared to evaluate the Caco-2 cell model. MTT assay and flow cytometry were used to investigate the effects of different concentrations of EPA on the survival rate and apoptosis rate of Caco-2 cells. RT-qPCR was used to measure the mRNA expression of ZO-1 in Caco-2 cells after EPA and/or E.coli LF82 treatment. ELISA was used to measure the change in the level of tumor necrosis factor-α (TNF-α) in culture supernatant.
RESULTS
After EPA treatment (25 and 50 μmol/L), the proliferation of Caco-2 cells was induced in a dose-dependent manner. The survival rates of the cells were significantly higher than those in the control group (P<0.05). The EPA treatment (100 and 200 μmol/L) groups had a significant inhibitory effect on the proliferation of Caco-2 cells in a dose-dependent manner. The survival rates of the cells were significantly lower than those in the control group (P<0.05). The EPA treatment (100 and 200 μmol/L) groups had a significant increase in cell apoptosis rate compared with the control group (P<0.05). The 6- and 12-hour E.coli LF82 treatment groups had decreasing mRNA expression of ZO-1 in Caco-2 cells over the time of treatment and had significantly lower mRNA expression of ZO-1 than the untreated group (P<0.05). The Caco-2 cells treated with E.coli LF82 and 25 or 50 μmol/L EPA for 6 or 12 hours showed an increase in the mRNA expression of ZO-1 with the increasing concentration of EPA, as well as significantly higher mRNA expression of ZO-1 than the Caco-2 cells treated with E.coli LF82 alone (P<0.05). The Caco-2 cells treated with E.coli LF82 alone for 6 or 12 hours had increasing secretion of TNF-α over the time of treatment and had significantly higher secretion than the untreated Caco-2 cells (P<0.05). The Caco-2 cells treated with E.coli LF82 and 25 or 50 μmol/L EPA for 6 or 12 hours showed a reduction in the secretion of TNF-α with the increasing concentration of EPA and had significantly lower secretion than the Caco-2 cells treated with E.coli LF82 alone (P<0.05).
CONCLUSIONS
EPA can effectively prevent the destruction of tight junction of intestinal epithelial cells induced by E.coli LF82 infection and inhibit the secretion of inflammatory factors. Therefore, it has a certain protective effect on intestinal mucosal barrier.
[1]
Sung Hee Lee,et al.
Intestinal Permeability Regulation by Tight Junction: Implication on Inflammatory Bowel Diseases
,
2015,
Intestinal research.
[2]
M. Furuse,et al.
ZO-1 Knockout by TALEN-Mediated Gene Targeting in MDCK Cells: Involvement of ZO-1 in the Regulation of Cytoskeleton and Cell Shape
,
2014,
PloS one.
[3]
Zhifeng Liu,et al.
Eicosapentaenoic Acid Enhances Heat Stress-Impaired Intestinal Epithelial Barrier Function in Caco-2 Cells
,
2013,
PloS one.
[4]
T. Lea,et al.
Omega-3 and omega-6 PUFAs induce the same GPR120-mediated signalling events, but with different kinetics and intensity in Caco-2 cells
,
2013,
Lipids in Health and Disease.
[5]
D. Rotondo,et al.
Eicosapentaenoic acid suppression of systemic inflammatory responses and inverse up‐regulation of 15‐deoxyΔ12,14 Prostaglandin J2 production
,
2013,
British journal of pharmacology.
[6]
N. K. Ho,et al.
Adherent–invasive Escherichia coli blocks interferon‐γ‐induced signal transducer and activator of transcription (STAT)‐1 in human intestinal epithelial cells
,
2013,
Cellular microbiology.
[7]
B. Chassaing,et al.
The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases.
,
2011,
Gastroenterology.
[8]
D. Antonetti,et al.
TNF-α Signals Through PKCζ/NF-κB to Alter the Tight Junction Complex and Increase Retinal Endothelial Cell Permeability
,
2010,
Diabetes.
[9]
J. Blanco,et al.
Molecular diversity of Escherichia coli in the human gut: New ecological evidence supporting the role of adherent‐invasive E. coli (AIEC) in Crohn's disease
,
2009,
Inflammatory bowel diseases.
[10]
J. Kvetina,et al.
Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver.
,
2011,
Acta medica.
[11]
A. Fanning,et al.
MOLECULAR STRUCTURE AND FUNCTION OF THE TIGHT JUNCTION Zonula Occludens-1 and -2 Are Cytosolic Scaffolds That Regulate the Assembly of Cellular Junctions
,
2009
.
[12]
A. Darfeuille‐Michaud,et al.
Adherent-invasive Escherichia coli: a putative new E. coli pathotype associated with Crohn's disease.
,
2002,
International journal of medical microbiology : IJMM.